Last reviewed · How we verify
NCT04595656: SEACTN-VA
Defining Causes of Deaths in South and Southeast Asia
trial testing verbal autopsy interview in Cause of Mortality in 3,413 participants. Completed in 30 April 2024.
30 April 2024
Quick facts
| Lead sponsor | University of Oxford |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 3,413 |
| Start date | 1 September 2021 |
| Primary completion | 30 April 2024 |
| Estimated completion | 30 April 2024 |
| Sites | 5 locations across Cambodia, Burma, Laos, Thailand, Bangladesh |
Drugs / interventions tested
- verbal autopsy interview
Conditions studied
- Cause of Mortality — all drugs for Cause of Mortality →
- Cause of Neonatal Death — all drugs for Cause of Neonatal Death →
- Cause of Child Death — all drugs for Cause of Child Death →
- Cause of Maternal Death — all drugs for Cause of Maternal Death →
Sponsor
University of Oxford
Who can join
18 and older, any sex, with Cause of Mortality or Cause of Neonatal Death. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Brief Summary: Mortality data are important in low and middle-income countries to assess the population health status and trends. Mortality statistics in the populations of Bangladesh, Myanmar and Lao PDR are considered as generally limited and a recent assessment of vital registration systems of those countries reported a poor performance of the death registration system. Majority of deaths occur at home in rural area of those countries without cause of death assigned. To address this problem, the investigators will use verbal autopsy (VA) method developed by WHO to ascertain the cause of a death based on an interview with a family member or caregiver of deceased person to obtain information about causes of death in study rural communities. Death related to a specific cause will be defined by ICD-10 codes and described as primary, secondary or underlying COD. The study is planned to conduct in approximately 390 rural village communities covered by Southeast Asia clinical trial network (SEACTN) network in proposed 3 countries. The study findings will help establish a better understanding in signs, symptoms, medical history and circumstances preceding death; prioritize future interventions for early and effective diagnostics and treatment for diseases and how to keep mortality surveillance ongoing in study rural settings. This study is funded by Welcome Trust. Welcome Trust grant reference number is \[215604/Z/19/Z\].
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ethical and cultural implications for conducting verbal autopsies in South and Southeast Asia: a qualitative study.
Htun NSN, Perrone C, Phyo AP, Sen A, et al · · 2023 · cited 4× · PMID 38081771 · DOI 10.1136/bmjgh-2023-013462
Verify or expand the search:
- PubMed search for NCT04595656
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Oxford trials
Trials by the same sponsor.
- NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
- NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
- NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
- NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
- NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04595656 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oxford
- Last refreshed: 18 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04595656.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing